期刊文献+

活化血浆凝固时间对血小板预防性输注及疗效评价 被引量:2

Evaluation of activated plasma clotting time test on prophylactic platelet transfusions
下载PDF
导出
摘要 目的分析活化血浆凝固时间(APCT)在预防性血小板输注中的应用价值。方法将100例血小板计数<50×109/L的患者根据有无出血表现,分为出血组(29例)和未出血组(71例)。所有患者均抽取静脉血进行血小板计数(PLT)和APCT测定。结果两组PLT和APCT比较差异有统计学意义(P<0.05),说明APCT出血的敏感性和特异性高于PLT;以APCT≥92s作为血小板输注的界点值,可有效预防由血小板减低引起的出血。结论 APCT可以反映血小板数量和质量的变化,也能较全面的评估血小板的输注疗效,预防性血小板输注的阂值确定为APCT≥92s是安全有效的。 Objective To investigate the clinical values of activated plasma clotting time test ( APCT) on prophylactic platelet transfusions. Methods 100 patients with platelet couts 50 × 10 9 / L,29 of 100 patients with bleeding symptoms ( petechiae,epistaxis) and 71 patients without,were involved in the test. Draw their venous blood and collected in sodium citrate,the platelet count and APCT test were performed. Results APCT in bleeding group was obviously prolonged contrast to the non -bleeding group' s. There were statistically significant differences between the two groups( P 0. 05) . The APCT was better than PLT for predicting the bleeding due to thrombocytopenia. Using APCT≥92 s as the cut -off point for prophylactic platelet transfusion would accurately predict major bleeding due to thrombocytopenia. Conclusion APCT reflects the variations of quantity and quality of platelet simultaneously,and can evaluate precisely the efficacy of platelet transfusion. APCT≥92 s as trigger is safety and less cost.
作者 刘静
出处 《中国实用医药》 2013年第24期28-29,共2页 China Practical Medicine
关键词 活化血浆凝固时间 预防性 血小板输注 血小板 Activated plasma clotting time test Prophylactic Platelet transfusion Platelet
  • 相关文献

参考文献5

二级参考文献12

  • 1卫生部.临床输血技术规范[S].卫医发[2000]184号
  • 2Chao FC, Kim BK, Houranieh AM, et al. Infusible platelet membrane microvesicles:a potential transfusion substitute for platelets. Transfusion, 1996,36:536-542.
  • 3Wandt H, Frank M, Gramatzki M, et al. Safety of the 1000/μ1 trigger for prophylactic platelet transfusion : prospective multicenter experience in 734 patients with acute myeloid leukemia. Blood,2000,96Suppl:3536a.
  • 4Wandt H, Frank M, Ehminger G, et al. Safty and cost effectiveness of a 10 × 10^9/L trigger for prophylactic platelet transfusions compared with the traditional 20 × 10^9/L trigger:a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood, 1995,91:3601.
  • 5Xiao HY, Matsubayashi H, Bonderman DP, et al. Generation of annexin V-positive platelets and shedding of microparticles with stimulus-dependent procoagulant activity during storage of platelets at 4 degrees C. Transfusion,2000,40:420-427.
  • 6Stejiskal D, Proskova J, Petrzelova A, et al. Application of cationic propyl gallate as inducer of thrombocyte aggregation for evaluation of effectiveness of antiaggregation therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub ,2001,145:69-74.
  • 7崔徐江.临床输血[M] //高峰.输血与输血技术.北京:人民卫生出版社,2003,146-150.
  • 8Xiao HY,Matsubayashi H,Bonderman DP,et al.Generation of annexinV-positive platelets and shedding of microparticles with stimulus-dependent procoagulant activity during storage of platelets at 4℃[J].Transfusion,2000,40(4):420-427.
  • 9贺石林.诊断试验的选择与判断[M]//李家增,王鸿利,韩忠朝.血液实验学.上海科学技术出版社,1997,642-649.
  • 10Stejiskal D,Proskova J,Petrzelova A,et al.Application of cationicpropyl gallate as inducer of thrombocyte aggregation for evaluation of effectiveness of antiaggregation therapy[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2001,145(2):69-74.

共引文献9

同被引文献19

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部